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Abstract
Background: Babesiosis is a zoonotic disease transmitted by the Ixodes tick species. Infection often results in sub-
clinical manifestations; however, patients with this disease can become critically ill. Splenic rupture has been a
previously reported complication of babesiosis, but treatment has always led to splenectomy. Asplenia places a
patient at greater risk for overwhelming post-splenectomy infection from encapsulated bacteria, Lyme disease,
Ehrlichia as well as Babesia microti. Therefore, avoiding splenectomy in these patients must be considered by the
physician; particularly, if the patient is at risk for re-infection by living in an endemic area.
Case Presentation: A 54 year-old male from the northeast United States presented with left upper quadrant
abdominal pain associated with fever, chills, night sweats and nausea. A full evaluation revealed active infection
with Babesia microti and multiple splenic lacerations. This patient was successfully treated with appropriate
pharmacological therapy and non-operative observation for the splenic injury.
Conclusion: Patients diagnosed with Babesia microti infection are becoming more common, especially in endemic
areas. Although clinical manifestations are usually minimal, this infection can present with significant injuries
leading to critical illness. We present the successful non-operative treatment of a patient with splenic rupture due
to babesiosis infection.
Introduction
Babesiosis, most commonly caused by Babesia microti
infection is becoming a more prevalent disease. In the
United States, Martha’s Vineyard, Nantucket, Shelter
Island, and Long Island are considered some of the
endemic areas for this infection[1]. Disease manisfesta-
tions range from subclinical to severe critical illness.
Spontaneous splenic rupture is a rare complication that
has been previously documented leading to emergent
splenectomy in all cases[2,3]. However, asplenia places
the patient at an increased risk for overwhelming post-
splenectomy infection and critical illness. Therefore,
splenic preservation should be a priority when treating a
patient with splenic rupture following babesiosis infec-
tion, particularly for those residing in endemic areas.
Prior to this case presentation, successful non-operative
treatment following splenicr u p t u r ed u et ob a b e s i o s i s
has not been reported.
Case Report
A 54 year-old male presented to a small community hos-
pital in eastern Massachusetts with complaints of dull
left upper quadrant abdominal pain, fever of 102.3
degrees Fahrenheit, nausea, chills, night sweats and dark
urine for 48 hours. The patient recently traveled in
Maine, northeastern Massachusetts, and Nantucket
Island, Massachusetts. During his travels these symptoms
progressed prompting him to seek medical attention.
The patient was noted to be leukopenic, thrombocytope-
nic, and anemic with peripheral blood smear showing
ring forms consistent with Babesia microti. A computed
tomography (CT) scan was performed revealing perisple-
nic fluid in the subphrenic region with an upper limits of
normal-sized spleen, and a small amount of free fluid in
the pelvis suggesting hemoperitoneum. The patient was
started on atovaquone and azithromycin and transferred
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patient reported improved abdominal pain.
The patient’s past medical history is significant for
Lyme disease, left rotator cuff surgery 8 weeks prior to
presentation, and a laparoscopic right inguinal hernia
repair. He denied any medications. The patient reported
travel in the upper east coast of the United States but
denied recent travel beyond that. Of note, he has two
homes both of which are in endemic areas of tick-borne
illnesses. The patient denied smoking, significant alcohol
use, and drug use.
On physical exam, vitals signs were as follows: tem-
perature 99.3 degrees (F), pulse 94 beats per minute,
blood pressure 133/80 mmHg, respiratory rate 20 breaths
per minute, oxygen saturation 99% on room air. In gen-
eral, the patient appeared pale but was awake, alert, and
oriented to person, place, and time. On inspection, the
abdominal exam revealed no rashes and negative Cullen
and Grey-Turner signs. There was minimal tenderness to
palpation of the left lower quadrant; otherwise, the
abdominal exam was benign. Furthermore, the remainder
of the physical exam was unremarkable.
Laboratory values were significant for white blood cell
count 4.0 × 10
9/L, hemoglobin 102 g/L (10.2 g/dL),
hematocrit 28.8%, platelet count 26.0 × 10
9/L, bilirubin
total 32.49 μmol/L (1.9 mg/dL), bilirubin direct 17.1
μmol/L (1.0 mg/dL), LDH 591 units/L, ALT 180 units/L,
AST 68 units/L, and alkaline phosphatase 116 units/L.
A repeat CT scan performed showed the spleen mea-
sured 14 cm in longitudinal length with multiple lacera-
tions (the largest extending near the hilum), and
perisplenic/perihepatic/peripelvic hemorrhage (Figure 1).
Infectious Disease (ID) and General Surgery were con-
sulted for further evaluation. ID reviewed the peripheral
blood smear and confirmed the presence of Babesiosis
with 3% parasitemia. Atovaquone and azithromycin
were continued with the addition of doxycycline for pre-
sumptive coverage of Lyme disease and Ehrlichiosis. The
patient was admitted to the surgical intensive care unit
for expectant management of the splenic injury which
included bed rest, serial abdominal exams, serial hemo-
globin/hematocrit checks, and platelet transfusion to a
goal of greater than 50.0 × 10
9/L.
Non-operative course of management was chosen for
several reasons. First, the patient was minimally sympto-
matic by the time of transfer with hemodynamically
normal vital signs. Second, the parasite count was 3%
indicating a high likelihood of prompt, successful
response to pharmacological therapy. Lastly, the patient
has a history of Lyme disease, and he resides in a highly
endemic region for tick-borne diseases. It was the belief
of the team that the patient would therefore be at signif-
icant risk for additional tick-borne illnesses in the
future, and if infected again would have a higher risk of
mortality if he were asplenic.
Blood cultures and DNA polymerase chain reaction
(PCR) studies were sent for Babesiosis, Lyme disease,
and Ehrlichiosis. Babesiosis serum IgG was low/normal
and IgM was positive, which was interpreted as equivo-
cal; however, Babesia PCR was positive for active infec-
tion. Borellia species PCR was negative and Ehrlichia
chaffensis IgG/IgM antibodies and PCR were also
negative.
The patient was observed in the hospital for four days
with improved symptoms each day. At the time of dis-
charge his leukopenia had resolved, hemoglobin
increased to 103 g/L (10.3 g/dL) from a low of 85 g/L
(8.5 g/dL). Platelets increased to 439.0 × 10
9/L from a
l o wo f2 6 . 0×1 0
9/L status post transfusion of 15 units,
and his bilirubin (direct and indirect) levels were also
normal at discharge. The patient received a 10-day
course of antibiotics in total. At his follow up appoint-
ment the patient was doing well and deemed appropri-
ate to resume normal activity.
Discussion
Babesia infection was first described in cattle by Babes
in 1888, and the first human case described by
Skrabalo in 1957[4,5]. Babesia is most commonly
caused by Babesia microti infection transmitted by
Ixodes scapularis, which is endemic in the northeast
Figure 1 Abdominal CT scan. The CT scan from this patient shows
a mildly enlarged spleen measuring 14 cm in longitudinal
dimension. He had multiple splenic lacerations however, and this
slice shows a 3.7 cm transverse splenic laceration.
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from Minnesota, Wisconsin, and outside of the United
States in Europe and Asia[2,7-9]. The European infec-
tion however is most often caused by Babesia divergens
[10]. In the United States, the geographical distribution
of babesiosis is similar to Lyme disease, which is trans-
mitted by the same tick, Ixodes scapularis. Although
less widespread than Lyme disease, the dissemination
of babesiosis is currently increasing. This may be due to
the growth of the white-tailed deer and white-footed
mouse population or simply due to increased awareness
and reporting of the disease[6,11]. In addition to tick
transmission, babesiosis can spread transplacentaly and
through blood transfusions[12,13].
Clinical presentation ranges from the asymptomatic
patient to the more critically ill patient. The intermedi-
ate disease includes nonspecific viral-like symptoms
such as chills, sweats, headache, arthralgia, anorexia,
cough, and nausea. On physical exam patients can pre-
sent with splenomegaly or hepatomegaly. Symptoms in
more severe disease include jaundice, retinal infarct,
ecchymoses, congestive heart failure, disseminated intra-
vascular coagulation, liver and renal failure, and splenic
rupture[6,14]. Common laboratory findings consist of
thrombocytopenia, normal to decreased leukocyte count,
and hemolytic anemia[14]. The most severe infections
occur in the elderly, immunocomprimised, or splenecto-
mized patients[10].
Diagnosis is determined by several methods. Micro-
scopic identification is performed using Wright’so r
Giemsa stain which identify the Babesia microti organ-
ism[10]. A common morphology observed on these
stains is a ring-form which has low specificity resem-
bling the classic “signet rings” seen in malaria (white
arrow, Figure 2). A pathognomonic but rare microscopic
form is the Maltese cross (black arrow, Figure 2)[14,15].
Confirmatory tests include serology and PCR. Serology
is utilized to identify positive IgG and IgM titers. PCR is
more specific and sensitive, and is suggested when
blood smears are non-conclusive[6].
The treatment of babesiosis traditionally consisted of
clindamycin and quinine, but this therapy has multiple
side effects including tinnitus,v e r t i g o ,a n dg a s t r o i n t e s t -
inal upset[14]. Data from 2000 shows that mild to mod-
erate disease can be treated with atovaquone and
azithromycin for 7 to 10 days with comparable results
and less side effects[16]. If there is no response to this
therapy or the disease is severe then the recommenda-
tion is to transition medical therapy back to clindamycin
and quinine[6,17]. Furthermore, exchange red blood cell
transfusion is an option in patients with severe parasite-
mia (>5-10%) or if there is pulmonary, renal, or hepatic
compromise[6,14,18,19].
Splenic injury is an uncommon complication of Babe-
sia infection. There are several reports of splenic rup-
ture as well as splenic infarction in the literature[2,3,20].
However, there are no reports describing successful
non-operative management of significant rupture. Our
institution has treated several patients in the past with
splenic lacerations. Of these cases, one was successfully
treated with splenic artery embolization and others with
splenectomy. Two case reports previously published pre-
sent a 61 year-old male and a 56 year-old male infected
with babesiosis that were initially treated with observa-
tion and antibiotic therapy alone. However, both
patients developed acute abdominal pain requiring
further work-up. CT scans demonstrated splenic lacera-
tion in both patients, and they subsequently underwent
emergent splenectomy due to worsening hemodynamic
instability. Parasite count was noted to be 5% for the 61
year-old male, and not reported for the other[2,3]. In
comparison to the two patients requiring operative
invention, our patient had a slightly lower parasite
count and received platelet transfusions. He was diag-
nosed early in his hospital course with a splenic rupture
and was aggressively monitored in the surgical intensive
care unit with serial abdominal exams.
The mechanism of splenic rupture is not entirely clear
but may be a result of phagocytosis of Babesia-infected
erythrocytes by splenic histiocytes in addition to seques-
tration of platelets causing thrombocytopenia. This pro-
cess leads to rapid splenomegaly and eventual splenic
rupture[2]. Splenomegaly was reported in only one of
the previously published case reports; therefore, a
benign abdominal exam cannot exclude splenic injury.
Figure 2 Peripheral blood smear. White arrow indicates
pleomorphic, ring like structures often found with Babesia infection
resembling early forms of malarial parasites such as Plasmodium
falciparum. Black arrow shows the classic arrangement of 4 rings
called the Maltese cross which is pathognomonic for Babesia
infection. Image provided courtesy of Daniele Focosi MD, University
of Pisa, Italy.
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may allow for early clinical management that may pre-
vent splenectomy in select cases. This is important, par-
ticularly in patients living in endemic areas, because
asplenia places a patient at greater risk for overwhelm-
ing post-splenectomy infection from encapsulated bac-
teria, Lyme disease, Ehrlichia as well as Babesia [10].
In asplenic patients, routine screening for Babesia may
be indicated for those living in endemic areas[1]. Patients
with babesiosis should also be screened for Lyme
disease and Erlichiosis at the time of infection because
co-infection often manifests as more severe disease[10].
Conclusion
The incidence of babesiosis infection is increasing
throughout the United States. This disease often presents
with mild to moderate symptoms, but can rapidly pro-
gress to significant injury including splenic rupture. Early
diagnosis, close observation, and platelet transfusions
allow for effective and successful non-operative treatment
for splenic rupture. Most importantly, avoidance of sple-
nectomy preserves optimal immunologic function against
re-infection for a patient residing in an endemic area.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
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